Hyloris Pharmaceuticals SA logo

HYL - Hyloris Pharmaceuticals SA Share Price

€12.2 0.4  3.0%

Last Trade - 9:44am

Sector
Healthcare
Size
Small Cap
Market Cap £263.3m
Enterprise Value £205.9m
Revenue £78.4k
Position in Universe 397th / 847
Bullish
Bearish
Unlock HYL Revenue
Momentum
Relative Strength (%)
1m +5.06%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -14.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.21 0.091 0.091 2.50 -34.6%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, HylorisPharmaceuticals SA revenues totaled EUR82K. Net losstotaled to EUR3.7M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HYL Revenue Unlock HYL Revenue

Net Income

HYL Net Income Unlock HYL Revenue

Normalised EPS

HYL Normalised EPS Unlock HYL Revenue

PE Ratio Range

HYL PE Ratio Range Unlock HYL Revenue

Dividend Yield Range

HYL Dividend Yield Range Unlock HYL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
HYL EPS Forecasts Unlock HYL Revenue
Profile Summary

Hyloris Pharmaceuticals is a Belgium-based specialty pharmaceutical company. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
No. of Shareholders: n/a
No. of Employees: 10
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Euronext - Brussels
Shares in Issue 25,832,632
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HYL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HYL
Upcoming Events for HYL
Frequently Asked Questions for Hyloris Pharmaceuticals SA
What is the Hyloris Pharmaceuticals SA share price?

As of 9:44am, shares in Hyloris Pharmaceuticals SA are trading at €12.2, giving the company a market capitalisation of £263.3m. This share price information is delayed by 15 minutes.

How has the Hyloris Pharmaceuticals SA share price performed this year?

Shares in Hyloris Pharmaceuticals SA are currently trading at €12.2 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Hyloris Pharmaceuticals SA price has moved by % over the past year.

What are the analyst and broker recommendations for Hyloris Pharmaceuticals SA?

There are no analysts currently covering Hyloris Pharmaceuticals SA.

When will Hyloris Pharmaceuticals SA next release its financial results?

Hyloris Pharmaceuticals SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Hyloris Pharmaceuticals SA dividend yield?

Hyloris Pharmaceuticals SA does not currently pay a dividend.

Does Hyloris Pharmaceuticals SA pay a dividend?

Hyloris Pharmaceuticals SA does not currently pay a dividend.

When does Hyloris Pharmaceuticals SA next pay dividends?

Hyloris Pharmaceuticals SA does not currently pay a dividend.

How do I buy Hyloris Pharmaceuticals SA shares?

To buy shares in Hyloris Pharmaceuticals SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Hyloris Pharmaceuticals SA?

Shares in Hyloris Pharmaceuticals SA are currently trading at €12.2, giving the company a market capitalisation of £263.3m.

Where are Hyloris Pharmaceuticals SA shares listed? Where are Hyloris Pharmaceuticals SA shares listed?

Here are the trading details for Hyloris Pharmaceuticals SA:

Country of listing: Belgium
Exchange: BRU
Ticker Symbol: HYL
What kind of share is Hyloris Pharmaceuticals SA?

Based on an overall assessment of its quality, value and momentum, Hyloris Pharmaceuticals SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Hyloris Pharmaceuticals SA share price forecast 2021?

Shares in Hyloris Pharmaceuticals SA are currently priced at €12.2. At that level they are trading at 26.69% discount to the analyst consensus target price of 0.00.

How can I tell whether the Hyloris Pharmaceuticals SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hyloris Pharmaceuticals SA. Over the past six months, the relative strength of its shares against the market has been 17.59%. At the current price of €12.2, shares in Hyloris Pharmaceuticals SA are trading at 13.24% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Hyloris Pharmaceuticals SA PE Ratio?

We were not able to find PE ratio data for Hyloris Pharmaceuticals SA.

Who are the key directors of Hyloris Pharmaceuticals SA?

We were unable to find the directors for Hyloris Pharmaceuticals SA.

Who are the major shareholders of Hyloris Pharmaceuticals SA?

Here are the top five shareholders of Hyloris Pharmaceuticals SA based on the size of their shareholding:

Van Rompay (Stijn) Individual Investor
Percentage owned: 26.42% (6.82m shares)
Jacobsen (Thomas) Individual Investor
Percentage owned: 13.31% (3.44m shares)
Versluys (Bart) Individual Investor
Percentage owned: 6.69% (1.73m shares)
Reunbrouck (Nick) Individual Investor
Percentage owned: 6.23% (1.61m shares)
Van Rompay (Pieter) Individual Investor
Percentage owned: 3.54% (915k shares)
Similar to HYL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.